5a-dihydrotestosterone ( 17/?-hydroxy-5a-androstan-3-one, DHT) converted from testosterone by the action of 5a-reductase in the target tissues is the major androgen. It binds to androgen receptor in the nuclei of the target cells and activates m-RNA to product the androgenic protein which is responsible for male phenotypic de¬ velopment in a case with chromosome of 46, XY (1, 2) . The insufficient action of DHT at the level of androgen receptor seriously impairs development of the male external genitalia. It is known as complete androgen insensitivity syndrome (CAIS) of an X chromosomelinked disorder and partial androgen insensitivity syn¬ drome, such as Reinfenstein syndrome (3, 4 (3) . After the binding of DHT to the androgen receptor, the DHT-AR complex interacts with hormone responsive elements which are present in specific target genes, and may modulate the transcriptional activity of their promoters (5) .
Since the human AR gene was first isolated in 1988 (6) (7) (8) , the genomic structure of the AR gene has been clarified (3, 9) . The AR gene is located in the X chromosome (Xql 1-12) (7, 10) and is divided into eight exons over a length of 90 kb (3, 9) . The N terminal domain of AR is encoded by exon A, and the DNA binding domain is encoded by exons B and C; the hormone-binding domain is encoded by exons D, E, F, G, H (3, 9) .
CAIS is caused by a target organ insensitivity at the levels of AR to DHT (11, 12) . Two variants of this syndrome have been identified (13) . In the first variant, the specific binding of DHT to the AR is undetectable or low in the target cells (receptor-negative). In the second variant, normal levels of intracellular AR for the binding of DHT are present but thermolabile under a certain condition (receptor-positive) (14) (15) (16) (17) (18) . In the patients with receptor-negative CAIS, the AR gene had mutations, such as deletion, and substitution in the exons or the splicing signal site (19) (20) (21) (22) (23) (27) . The converted to cytosine (Fig. la) . Since the codon GGG changed to GCG in the subject's exon G DNA, the glycine would be replaced with alanine in the amino acid sequence (Fig. lb) (Fig. 2b) (29) . In our case, the position of the mutation in exon G was different from theirs. The AR is a member of the nuclear receptor superfamily, to which the receptors for progesterone, glucocorticoid, mineralcorticoid, and estrogen also belong. Within this superfamily, the homology of the hormone-binding domain of the AR was 54% with the progesterone receptor, 50% with the glucocorticoid receptor, and 51% with the mineral corticoid receptor (Fig. 3) . There are also highly con¬ served amino acids in this family, especially in the hormone-binding domain. These conserved amino acids may play an important role in the fundamental receptor structure, or binding activity. In our subject, the point mutation of exon G caused the replacement of a weak polar glycine to a weak hydrophobic alanine, and the position of the amino acid replacement was located within the conserved region of the nuclear receptor family (Fig. 3) (30) . One replacement (arginine->cys-teine) caused the absence of AR binding activity, whereas the other replacement (arginine->histidine) caused the thermolability of AR binding activity. This result suggests that amino acid itself may play an important role in the structure of AR. The numerous genetic studies in CAIS with positive or negative AR will give much more information about the structure of AR.
